The company has demonstrably boosted this development of an innovative solution for ATTR-CM, leveraging the compound. Early patient information reveals promising benefits for individuals affected by this severe illness. This emphasis highlights BridgeBio's dedication to addressing significant medical demands in a heart space. Attruby: BridgeBio's